Stone disease, also called urolithiasis, is a painful and common urologic disorder with more than one million kidney stone cases diagnosed each year. Kidney stones form in the kidney and ureteral stones are kidney stones that move into the ureter. Once a patient develops a stone, there is a 50 percent risk of recurrence within five years and an 80 percent risk of stones returning within 10 years.
Brigham and Women’s Faulkner Hospital provides the most advanced diagnostic technologies and treatment strategies available for treating kidney stones in adults. Our board certified urologic surgeons have successfully treated thousands of patients using innovative, minimally invasive procedures such as stone ablation with shock waves and endoscopic or percutaneous surgery to break up and extract stones—proven options that are safe, speed recovery time and reduce recurrence.
Our urology practice consists of board certified urologic surgeons and a supportive clinical and administrative staff who work as one cohesive team to provide the best possible care for each patient. In addition, patients have full access to Brigham and Women's Hospital, a world-renowned academic medical center in Boston with a diverse multidisciplinary specialists and state-of-the-art facilities.
You will receive a thorough diagnostic evaluation and receive clinically-proven treatment by a board-certified urologist who specializes in treating kidney stones. Recovery times vary depending upon surgical treatment, with less invasive procedures having shorter recovery times. You will be encouraged to drink extra fluid post-operatively and may need follow-up blood and urine tests.
Brigham and Women’s Faulkner Hospital practices a multidisciplinary approach to patient care, routinely collaborating with colleagues in other medical specialties. If your urologist discovers that an underlying illness has contributed to the kidney stones, you will be referred to an appropriate BWFH or BWH physician for an evaluation.